Carcinoma
|
0.320 |
Biomarker
|
group |
CTD_human |
cDNA microarray profiling of rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 7,12-dimethylbenz[a]anthracene.
|
12376462 |
2002 |
Carcinoma
|
0.320 |
AlteredExpression
|
group |
BEFREE |
RT-PCR products with the predicted size and sequence of PTI-1 are detected in RNAs from cell lines of human prostate, breast, and colon carcinomas.
|
8988032 |
1997 |
Carcinoma
|
0.320 |
AlteredExpression
|
group |
BEFREE |
By using a pair of primers recognizing a 280-bp region within the 630-bp 5' PTI-1 sequence, reverse transcription-PCR detects PTI-1 expression in patient-derived prostate carcinomas but not in normal prostate or benign hypertrophic prostate tissue.
|
7542776 |
1995 |
Malignant neoplasm of stomach
|
0.300 |
Biomarker
|
disease |
CTD_human |
Two-dimensional differential in-gel electrophoresis for identification of gastric cancer-specific protein markers.
|
19424620 |
2009 |
Stomach Neoplasms
|
0.300 |
Biomarker
|
group |
CTD_human |
Two-dimensional differential in-gel electrophoresis for identification of gastric cancer-specific protein markers.
|
19424620 |
2009 |
Hereditary Diffuse Gastric Cancer
|
0.300 |
Biomarker
|
disease |
CTD_human |
Two-dimensional differential in-gel electrophoresis for identification of gastric cancer-specific protein markers.
|
19424620 |
2009 |
Animal Mammary Neoplasms
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
cDNA microarray profiling of rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 7,12-dimethylbenz[a]anthracene.
|
12376462 |
2002 |
Mammary Neoplasms, Experimental
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
cDNA microarray profiling of rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 7,12-dimethylbenz[a]anthracene.
|
12376462 |
2002 |
Anaplastic carcinoma
|
0.300 |
Biomarker
|
disease |
CTD_human |
cDNA microarray profiling of rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 7,12-dimethylbenz[a]anthracene.
|
12376462 |
2002 |
Carcinoma, Spindle-Cell
|
0.300 |
Biomarker
|
disease |
CTD_human |
cDNA microarray profiling of rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 7,12-dimethylbenz[a]anthracene.
|
12376462 |
2002 |
Undifferentiated carcinoma
|
0.300 |
Biomarker
|
disease |
CTD_human |
cDNA microarray profiling of rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 7,12-dimethylbenz[a]anthracene.
|
12376462 |
2002 |
Carcinomatosis
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
cDNA microarray profiling of rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 7,12-dimethylbenz[a]anthracene.
|
12376462 |
2002 |
Mammary Carcinoma, Animal
|
0.300 |
Biomarker
|
disease |
CTD_human |
cDNA microarray profiling of rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 7,12-dimethylbenz[a]anthracene.
|
12376462 |
2002 |
Osteoarthritis, Knee
|
0.200 |
Biomarker
|
disease |
RGD |
Proteomic analysis of rat cartilage: the identification of differentially expressed proteins in the early stages of osteoarthritis.
|
25435813 |
2014 |
Red cell distribution width determination
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
RDW - Red blood cell distribution width result
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Malignant Neoplasms
|
0.070 |
AlteredExpression
|
group |
BEFREE |
Reciprocal relationship of differential expression between EEF1A isoforms observed in multiple cancer types indicates opposing roles in cancer and needs further investigation.
|
29342219 |
2018 |
Malignant Neoplasms
|
0.070 |
Biomarker
|
group |
BEFREE |
Encoded by EEF1A1, the eukaryotic translation elongation factor eEF1α1 strongly promotes the heat shock response, which protects cancer cells from proteotoxic stress, following for instance oxidative stress, hypoxia or aneuploidy.
|
30224719 |
2018 |
Primary malignant neoplasm
|
0.070 |
Biomarker
|
group |
BEFREE |
Encoded by EEF1A1, the eukaryotic translation elongation factor eEF1α1 strongly promotes the heat shock response, which protects cancer cells from proteotoxic stress, following for instance oxidative stress, hypoxia or aneuploidy.
|
30224719 |
2018 |
Primary malignant neoplasm
|
0.070 |
AlteredExpression
|
group |
BEFREE |
Reciprocal relationship of differential expression between EEF1A isoforms observed in multiple cancer types indicates opposing roles in cancer and needs further investigation.
|
29342219 |
2018 |
Malignant Neoplasms
|
0.070 |
AlteredExpression
|
group |
BEFREE |
Given that deregulated mRNA translation is a frequent feature of cancer and that eEF1A1 is highly expressed in many human tumours, these findings present new possibilities for the therapeutic targeting of EZH2 in AML.
|
28678185 |
2017 |
Primary malignant neoplasm
|
0.070 |
AlteredExpression
|
group |
BEFREE |
Given that deregulated mRNA translation is a frequent feature of cancer and that eEF1A1 is highly expressed in many human tumours, these findings present new possibilities for the therapeutic targeting of EZH2 in AML.
|
28678185 |
2017 |
Malignant Neoplasms
|
0.070 |
Biomarker
|
group |
BEFREE |
These suggested eEF1A1 as a molecular marker to predict the selectivity and efficiency of 5-ALA based PDT in cancer therapy.
|
27150264 |
2016 |
Primary malignant neoplasm
|
0.070 |
Biomarker
|
group |
BEFREE |
These suggested eEF1A1 as a molecular marker to predict the selectivity and efficiency of 5-ALA based PDT in cancer therapy.
|
27150264 |
2016 |
Malignant Neoplasms
|
0.070 |
AlteredExpression
|
group |
BEFREE |
Nannocystin A (1) displayed differential activity across various cancer cell lines and EEF1A1 expression levels appear to be the main differentiating factor.
|
26179970 |
2015 |